Restenosis and Therapy
The vascular disease involves imbalanced function of the blood vessels. Risk factors playing a role in development of impaired vessel functions will be briefly discussed. In ischemia/reperfusion (I/R), ischemic hypoxia is one of the cardinal risk factors of restenosis. Various insults are shown to i...
Saved in:
Main Authors: | Laszlo Denes, Laszlo Entz, Veronika Jancsik |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Vascular Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/406236 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Stent Restenosis Predictors after Carotid Artery Stenting
by: Mirco Cosottini, et al.
Published: (2010-01-01) -
Preliminary Study by Differential Scanning Calorimetric Analysis of Red Blood Cells in Peripheral Artery Disease Patients Treated with Cilostazol: Correlation with Improvements in Walking Distance
by: Dénes Lőrinczy, et al.
Published: (2025-01-01) -
Novel Use of an Orbital Atherectomy Device for In-Stent Restenosis: Lessons Learned
by: K. Shaikh, et al.
Published: (2016-01-01) -
Inorganic nitrates to prevent in-stent restenosis. Is nitric oxide the Philosopher's stone?
by: Fernando Alfonso, et al.
Published: (2025-01-01) -
Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
by: Michael H. Vu, et al.
Published: (2022-01-01)